Biogen inches higher: trade running, risk zeroed, first window approaching

Biogen is in its 5th week of a buy signal, up 3.4% from entry. The setup quality, at 62 out of 100 in an ordinary phase, is gradually improving; signal strength at 47 reflects a trade holding direction without accelerating. The stock is hugging near-term highs — a heavily contested level — and the stop has been moved to breakeven: position risk is zeroed. The first management window is 1 week away.